Works matching IS 13520504 AND DT 2022 AND VI 29 AND IP 6
Results: 11
Cover Image.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. i, doi. 10.1111/jvh.13683
- Publication type:
- Article
Prevalence of hepatitis C in sexual assault survivors presenting to a SANE clinic: A descriptive analysis.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 487, doi. 10.1111/jvh.13675
- By:
- Publication type:
- Article
Hepatitis B core‐related antigen serum levels are associated with significant liver fibrosis in treatment‐naive chronic HBV infection patients.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 438, doi. 10.1111/jvh.13674
- By:
- Publication type:
- Article
Mortality in Greenlanders with chronic hepatitis B virus infection.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 432, doi. 10.1111/jvh.13673
- By:
- Publication type:
- Article
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 474, doi. 10.1111/jvh.13672
- By:
- Publication type:
- Article
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 420, doi. 10.1111/jvh.13671
- By:
- Publication type:
- Article
Decreasing prevalence and stagnating incidence of Hepatitis C‐co‐infection among a cohort of HIV‐1‐positive patients, with a majority of men who have sex with men, in Germany, 1996–2019.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 465, doi. 10.1111/jvh.13670
- By:
- Publication type:
- Article
Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long‐term follow‐up study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 412, doi. 10.1111/jvh.13667
- By:
- Publication type:
- Article
Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 447, doi. 10.1111/jvh.13652
- By:
- Publication type:
- Article
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open‐label, phase 2 study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 455, doi. 10.1111/jvh.13650
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 409, doi. 10.1111/jvh.13536
- Publication type:
- Article